Lv7
5000 积分 2021-12-15 加入
Cell-penetrating asymmetric siRNA targeting MyD88 suppresses inflammasome-driven ocular degeneration and angiogenesis
4天前
已完结
Cell-penetrating asymmetric siRNA targeting MyD88 suppresses inflammasome-driven ocular degeneration and angiogenesis
14天前
已完结
Development of a dual functional RNAi therapeutic, ARO-DIMER-PA, for mixed hyperlipidemia
26天前
已完结
High-Throughput Experimentation Reveals Scope and Limitations of Selective Phosphine Reductants and Enables One-Pot mAb Reduction/Conjugation
3个月前
已完结
Site-Specific Conjugation to Cys-Engineered THIOMAB™ Antibodies
3个月前
已完结
Advancing immunotherapy with innovations in CAR-M engineering for cancer treatment
4个月前
已完结
Enrichment and separation of recombinant adeno-associated virus particles by aqueous two-phase extraction
4个月前
已完结
Lipid nanoparticles produce chimeric antigen receptor macrophages (CAR-M) in situ for the treatment of solid tumors
4个月前
已完结
Synthetic SIGLEC9-based chimeric switch receptor augments the efficacy of CAR macrophages against glioblastoma
4个月前
已完结
Ocular RNA nanomedicine: engineered delivery nanoplatforms in treating eye diseases
5个月前
已完结
皖公网安备34019202002308
